Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China

Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies

(2022) Qi Xiang et al.   MICROBIOLOGICAL RESEARCH

Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile

(2022) M Elvira Balcells et al.   CLINICAL INFECTIOUS DISEASES

Adaptive immunity to SARS-CoV-2 and COVID-19

(2021) Alessandro Sette et al.   CELL

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

(2021) Sharon Amit et al.   LANCET

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

(2021) Zhiwei Wu et al.   LANCET INFECTIOUS DISEASES

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

(2021) Shilong Yang et al.   LANCET INFECTIOUS DISEASES

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

(2021) Nicholas G. Davies et al.   NATURE

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

(2021) Chang Liu et al.   CELL

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1

(2021) Itzchak Levy et al.   CLINICAL MICROBIOLOGY AND INFECTION

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

(2021) Aziz Sheikh et al.   LANCET

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

(2021) Moriah Bergwerk et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

(2021) Pinja Jalkanen et al.   Nature Communications

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

(2021) John Frater et al.   Lancet HIV

T follicular helper cells in the humoral immune response to SARS‐CoV‐2 infection and vaccination

(2021) Marios Koutsakos et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India)

(2021) Nitin Khandelwal et al.   Frontiers in Cellular and Infection Microbiology

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine

(2021) Felipe Melo-González et al.   Frontiers in Immunology

Prioritise people with HIV for COVID-19 vaccination

(2021) The Lancet HIV   Lancet HIV

Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

(2021) Xueying Yang et al.   Lancet HIV

COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity

(2021) Ying Liu et al.   Vaccines

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

(2020) Jianhui Nie et al.   Nature Protocols

Determinants of suboptimal CD4 + T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection

(2020) Ryan Handoko et al.   Journal of the International AIDS Society

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

(2020) Yanjun Zhang et al.   LANCET INFECTIOUS DISEASES

T Follicular Helper Cell Biology: A Decade of Discovery and Diseases

(2019) Shane Crotty   IMMUNITY

No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi

(2018) A.B. Ibarz-Pavon et al.   VACCINE

Current status on the development of pseudoviruses for enveloped viruses

(2017) Qianqian Li et al.   REVIEWS IN MEDICAL VIROLOGY